Cargando…
JAK-STAT Inhibitors in Atopic Dermatitis from Pathogenesis to Clinical Trials Results
A common disease worldwide is known as atopic dermatitis (AD), named also as atopic eczema, which is a chronic recurrent complex inflammatory skin disorder. It affects 2–10% of the adult population and up to 20% of the pediatric population. The clinical AD picture appears in typically localized ecze...
Autores principales: | Szalus, Krzysztof, Trzeciak, Magdalena, Nowicki, Roman J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694787/ https://www.ncbi.nlm.nih.gov/pubmed/33172122 http://dx.doi.org/10.3390/microorganisms8111743 |
Ejemplares similares
-
New Cytokines in the Pathogenesis of Atopic Dermatitis—New Therapeutic Targets
por: Klonowska, Jolanta, et al.
Publicado: (2018) -
The Associations of Single Nucleotide Polymorphisms of the COL3A1, COL6A5, and COL8A1 Genes with Atopic Dermatitis
por: Szalus, Krzysztof, et al.
Publicado: (2023) -
JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
por: Huang, I-Hsin, et al.
Publicado: (2022) -
Molecular Mechanisms of Atopic Dermatitis Pathogenesis
por: Sroka-Tomaszewska, Jowita, et al.
Publicado: (2021) -
Combination of FLG mutations and SNP of TSLP (rs1898671) influence on atopic dermatitis occurrence
por: Klonowska, Jolanta, et al.
Publicado: (2021)